Bal Pharma

Bal Pharma Diluted EPS

The Diluted Earnings per Share of Bal Pharma (BALPHARMA.NS) as of Oct 18, 2026 is 3.95 INR. In the previous year, Diluted Earnings per Share was 4.53 INR — a change of -12.92% (lower).

Diluted EPS

3.95INR

YoY

-12.92%

Last updated:

Diluted Earnings per Share of Bal Pharma is 2026 3.95 INR. Diluted Earnings per Share of Bal Pharma was 2025 4.53 INR. It decreases by -12.92% lower compared to the previous year.

The Bal Pharma Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2019
2.67 INR
Jan 1, 2020
-10.79 INR
Jan 1, 2021
3.20 INR
Jan 1, 2022
3.79 INR
Jan 1, 2023
1.63 INR
Jan 1, 2024
5.07 INR
Jan 1, 2025
4.53 INR
Jan 1, 2026
3.95 INR
The Bal Pharma Diluted EPS history
YEARDiluted EPSYoY
3.95INR-12.92%
4.53INR-10.60%
5.07INR+211.53%
1.63INR-57.02%
3.79INR+18.33%
3.20INR-129.65%
-10.79INR-503.79%
2.67INR+35.86%
1.97INR+41.58%
1.39INR+39.74%
0.99INR-65.91%
2.92INR-44.33%
5.24INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bal Pharma Stock analysis

What does Bal Pharma do? Bal Pharma Ltd., headquartered in Bangalore, India, operates in the Health Care sector, specializing in pharmaceuticals. The company develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs), focusing on therapeutic areas such as anti-diabetes, cardiology, and dermatology. It offers a range of products including bulk actives, generics, prescription drugs, and natural medicines like ANARSHA and AYURFINE. Listed on the stock exchange since 1995, Bal Pharma serves both domestic and international markets. Bal Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bal Pharma stock

Diluted Earnings per Share of Bal Pharma is 3.95 INR in 2026.

Diluted Earnings per Share of Bal Pharma changed from 4.53 INR to 3.95 INR, representing a -12.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Bal Pharma since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bal Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bal Pharma